FMP
Jan 20, 2026
Bloom Energy Corporation, listed on the NYSE under the symbol BE, is a prominent player in the clean energy sector. The company focuses on providing innovative power solutions, particularly in the realm of distributed energy. As of January 20, 2026, RBC Capital set a price target of $143 for Bloom Energy, while the stock was trading at approximately $151.95. This suggests a price difference of about -5.89% from the target.
Despite the price target set by RBC Capital, Bloom Energy has experienced a significant surge in its stock price, rising by 62.1% over the past month. This performance is impressive, especially when compared to the Zacks Alternative Energy - Other industry's decline of 1.7% and the Zacks Oil and Energy sector's gain of 5.2%. The broader Zacks S&P 500 Composite also saw a modest increase of 1.2% during the same period.
The driving force behind Bloom Energy's strong momentum is the growing demand for clean power, particularly from AI-focused data centers. Additionally, there is a shift towards distributed energy solutions to overcome transmission and distribution challenges. This demand has contributed to the stock's impressive performance, despite the price target set by RBC Capital.
Bloom Energy's return on invested capital (ROIC) stands at 5.22%, surpassing the industry average. Its forward price-to-sales (P/S) ratio is trading at a premium of 13.02 times. In contrast, Talen Energy Corporation, another player in the same sector, has seen a decline of 1.9% over the same timeframe. This highlights Bloom Energy's strong position in the market.
Currently, Bloom Energy's stock is priced at $151.66, reflecting a 1.45% rise with a price increase of $2.16. The stock has fluctuated between a low of $143.20 and a high of $155.31 today. Over the past year, it has reached a high of $155.24 and a low of $15.15. The company's market capitalization is approximately $35.87 billion, with a trading volume of 10.94 million shares.
U.S. Bancorp (NYSE:USB) is a major player in the American banking sector, ranking as the fifth-largest lender in the Uni...
RAPT Therapeutics (NASDAQ:RAPT) is a biopharmaceutical company based in California, specializing in developing treatment...